The Shmooze

'Rhoda' Actress's Cancer Miracle

By Reuters

  • Print
  • Share Share
getty images
Valerie Harper

Actress Valerie Harper’s brain cancer is nearing remission, her physician said in an excerpt of a documentary that was shown on NBC’s “Today” show.

“I’d say that we’re getting pretty close to remission,” neuro-oncologist Dr. Jeremy Rudnick said in a documentary that will air next month on the U.S. network.

“It defies the odds,” he added, as Harper sat listening to the results of tests conducted in June.

Harper, 74, won four Emmy Awards for her signature role of Rhoda Morgenstern on the hit 1970s sitcoms “The Mary Tyler Moore Show” and spin-off “Rhoda.” The actress said in March that her diagnosis of leptomeningeal carcinomatosis - cancer in the membrane of her brain - meant she had as little as three months to live.

In June, NBC announced that it was shooting a documentary about Harper and her treatment.

Rudnick cautioned in the segment that resistance to treatment is all-but-assured, saying, “it’s not a matter of if, but of when.” The actress has received treatment ranging from chemotherapy to acupuncture.

“I am afraid of what’s ahead,” Harper said. “But, so what? There’s much to be afraid of in life.”

Harper completed a tour promoting her new autobiography “I, Rhoda” shortly before going public with her illness. Last year she starred on Broadway as actress Tallulah Bankhead in “Looped,” for which she earned a Tony nomination.

Harper has continued to work since her diagnosis, notably in an upcoming episode of the cable comedy series “Hot in Cleveland” in which she guest-starred with former cast mates Mary Tyler Moore, Cloris Leachman and series regular Betty White.


Permalink | | Share | Email | Print | Filed under: valerie harper, mary tyler moore, rhoda, cancer

The Jewish Daily Forward welcomes reader comments in order to promote thoughtful discussion on issues of importance to the Jewish community. In the interest of maintaining a civil forum, The Jewish Daily Forwardrequires that all commenters be appropriately respectful toward our writers, other commenters and the subjects of the articles. Vigorous debate and reasoned critique are welcome; name-calling and personal invective are not. While we generally do not seek to edit or actively moderate comments, our spam filter prevents most links and certain key words from being posted and The Jewish Daily Forward reserves the right to remove comments for any reason.




Find us on Facebook!
  • Taglit-Birthright Israel is redefining who they consider "Jewish" after a 17% drop in registration from 2011-2013. Is the "propaganda tag" keeping young people away?
  • Happy birthday William Shakespeare! Turns out, the Bard knew quite a bit about Jews.
  • Would you get to know racists on a first-name basis if you thought it might help you prevent them from going on rampages, like the recent shooting in Kansas City?
  • "You wouldn’t send someone for a math test without teaching them math." Why is sex ed still so taboo among religious Jews?
  • Russia's playing the "Jew card"...again.
  • "Israel should deal with this discrimination against Americans on its own merits... not simply as a bargaining chip for easy entry to the U.S." Do you agree?
  • For Moroccan Jews, the end of Passover means Mimouna. Terbhou ou Tse'dou! (good luck) How do you celebrate?
  • Calling all Marx Brothers fans!
  • What's it like to run the Palestine International Marathon as a Jew?
  • Does Israel have a racism problem?
  • This 007 hates guns, drives a Prius, and oh yeah — goes to shul with Scarlett Johansson's dad.
  • Meet Alvin Wong. He's the happiest man in America — and an observant Jew. The key to happiness? "Humility."
  • "My first bra was a training bra, a sports bra that gave the illusion of a flat chest."
  • "If the people of Rwanda can heal their broken hearts and accept the Other as human, so can we."
  • Aribert Heim, the "Butcher of Mauthausen," died a free man. How did he escape justice?
  • from-cache

Would you like to receive updates about new stories?




















We will not share your e-mail address or other personal information.

Already subscribed? Manage your subscription.